Ning Feng 1/23/25 Ning Feng 1/23/25

AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology

Read More

Guest User 1/16/25 Guest User 1/16/25

JPM25: The FDA’s future, AbbVie’s second thoughts and Lilly’s lesson

Read More

Guest User 1/16/25 Guest User 1/16/25

‘The bar has risen’: China’s biotech gains push US companies to adapt

Read More

Guest User 1/14/25 Guest User 1/14/25

Biopharma Deals Start Flowing at JPM25—With One Dwarfing Last Year’s Activity

Read More

Guest User 1/13/25 Guest User 1/13/25

The Top 10 Biopharma M&A Deals of 2024

Read More

Ning Feng 11/14/24 Ning Feng 11/14/24

Merck signs up to $3.3 billion cancer drug deal with China-based LaNova

Read More

Guest User 11/13/24 Guest User 11/13/24

BioNTech to Acquire Biotheus to Boost Oncology Strategy

Read More

Guest User 11/7/24 Guest User 11/7/24

VC Aditum Bio hatches autoimmune-focused Oblenio Bio with asset from Chinese biotech

Read More

Guest User 10/31/24 Guest User 10/31/24

AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics

Read More

Guest User 10/29/24 Guest User 10/29/24

Novartis' $2.9B MorphoSys bet stumbles as safety signal delays filing by years

Read More

Guest User 10/29/24 Guest User 10/29/24

GSK enters agreement to acquire CMG1A46 from Chimagen Biosciences to expand immunology pipeline

Source: GSK plc

Read More

Guest User 10/8/24 Guest User 10/8/24

US Venture Capital Opens Path to Funding for China Biotech Firms

Read More

Guest User 8/29/24 Guest User 8/29/24

Can China Tech Find a Home in Silicon Valley?

Read More

Guest User 8/27/24 Guest User 8/27/24

Duality plans Hong Kong IPO to fund trials of BioNTech-partnered ADCs and beyond

Read More

Guest User 8/16/24 Guest User 8/16/24

Genentech to shut down cancer immunology research department amid broader R&D rethink

Source: Genentech/Roche

Read More

Guest User 2/7/24 Guest User 2/7/24

AIM-HI Accelerator Fund celebrates Yiviva's milestone collaboration with AstraZeneca China, furthering technology platforms for multiple cancers

Source: Yiviva

Read More

Ning Feng 11/10/23 Ning Feng 11/10/23

Fierce Pharma Asia—AstraZeneca's GLP-1 play; Takeda's cancer drug approval; BioNTech's bispecific deal

Read More

Tianjun Song 5/17/23 Tianjun Song 5/17/23

Zion Pharma Announces Global Agreement with Roche to Develop and Commercialize a Blood Brain Barrier Penetrant Oral HER2 Tyrosine Kinase Inhibitor

Read More

Tianjun Song 4/4/23 Tianjun Song 4/4/23

BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors

Read More

Tianjun Song 3/20/23 Tianjun Song 3/20/23

BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications

Read More